AnteoTech (ASX:ADO) Debt-to-Equity : 0.29 (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is AnteoTech Debt-to-Equity?

AnteoTech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$0.63 Mil. AnteoTech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$1.64 Mil. AnteoTech's Total Stockholders Equity for the quarter that ended in Dec. 2024 was A$7.70 Mil. AnteoTech's debt to equity for the quarter that ended in Dec. 2024 was 0.29.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for AnteoTech's Debt-to-Equity or its related term are showing as below:

ASX:ADO' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.14 Max: 2.5
Current: 0.29

During the past 13 years, the highest Debt-to-Equity Ratio of AnteoTech was 2.50. The lowest was 0.00. And the median was 0.14.

ASX:ADO's Debt-to-Equity is ranked worse than
63.39% of 1016 companies
in the Biotechnology industry
Industry Median: 0.14 vs ASX:ADO: 0.29

AnteoTech Debt-to-Equity Historical Data

The historical data trend for AnteoTech's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AnteoTech Debt-to-Equity Chart

AnteoTech Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Debt-to-Equity

Get a 7-Day Free Trial

0.04

0.06

0.08

0.55

0.44

AnteoTech Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial															0.14	0.55	0.21	0.44	0.29

Competitive Comparison of AnteoTech's Debt-to-Equity

For the Biotechnology subindustry, AnteoTech's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AnteoTech's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AnteoTech's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where AnteoTech's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

AnteoTech Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

AnteoTech's Debt to Equity Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.623	+	1.688)	/	5.306
	=	0.44

AnteoTech's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.628	+	1.639)	/	7.702
	=	0.29

AnteoTech (ASX:ADO) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

AnteoTech Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of AnteoTech's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AnteoTech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnteoTech Ltd (ASX:ADO) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

4/26 Brandl Street, Eight Mile Plains, Brisbane, QLD, AUS, 4113

Website

https://www.anteotech.com

AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its key areas are the Energy and Life Science Division. The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the AnteoTech IP.

AnteoTech Headlines

No Headlines